CoChat

Alpha‐synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation

Open access
Betzer, Cristine, Lassen, Louise Berkhoudt, Olsen, Anders, Kofoed, Rikke Hahn, Reimer, Lasse, Gregersen, Emil, Zheng, Jin, Calì, Tito, Gai, Wei‐Ping, Chen, Tong, Moeller, Arne, Brini, Marisa, Fu, Yuhong, Halliday, Glenda, Brudek, Tomasz, Aznar, Susana, Pakkenberg, Bente, Andersen, Jens Peter, Jensen, Poul Henning · 2018 · EMBO reports
Cited by 125

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Aggregation of α‐synuclein is a hallmark of Parkinson's disease and dementia with Lewy bodies. We here investigate the relationship between cytosolic Ca2+ and α‐synuclein aggregation. Analyses of cell lines and primary culture models of α‐synuclein cytopathology reveal an early phase with reduced cytosolic Ca2+ levels followed by a later Ca2+ increase. Aggregated but not monomeric α‐synuclein binds to and activates SERCA in vitro, and proximity ligation assays confirm this interaction in cells. The SERCA inhibitor cyclopiazonic acid (CPA) normalises both the initial reduction and the later increase in cytosolic Ca2+. CPA protects the cells against α‐synuclein‐aggregate stress and improves viability in cell models and in Caenorhabditis elegans in vivo. Proximity ligation assays also reveal an increased interaction between α‐synuclein aggregates and SERCA in human brains affected by dementia with Lewy bodies. We conclude that α‐synuclein aggregates bind SERCA and stimulate its activity. Reducing SERCA activity is neuroprotective, indicating that SERCA and down‐stream processes may be therapeutic targets for treating α‐synucleinopathies. Aggregated α‐synuclein stimulates the calcium pump SERCA thereby reducing cytosolic Ca2+ and contributing to neurodegeneration. Pharmacological SERCA inhibition protects against α‐synuclein aggregate stress with potential therapeutic implications. Aggregated α‐synuclein stimulates the calcium pump SERCA thereby reducing cytosolic Ca2+ and contributing to neurodegeneration. Pharmacological SERCA inhibition protects against α‐synuclein aggregate stress with potential therapeutic implications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/embr.201744617

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 125

Metadata

Authors
Betzer, C., Lassen, L. B., Olsen, A., Kofoed, R. H., Reimer, L., Gregersen, E., Zheng, J., Calì, T., Gai, W., Chen, T., Moeller, A., Brini, M., Fu, Y., Halliday, G., Brudek, T., Aznar, S., Pakkenberg, B., Andersen, J. P., & Jensen, P. H.
Venue
EMBO reports
Published
2018-03-29
Volume
19
Issue
5
ISSN
  • 1469-221X (ISSN-L)
  • 1469-3178
OpenAlex
W2795236460
Cited by
125
References
9
FWCI
8.00
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Alpha‐synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation. https://app.cochat.ai/papers/10.15252/embr.201744617
The paper
Betzer, C., Lassen, L. B., Olsen, A., Kofoed, R. H., Reimer, L., Gregersen, E., Zheng, J., Calì, T., Gai, W., Chen, T., Moeller, A., Brini, M., Fu, Y., Halliday, G., Brudek, T., Aznar, S., Pakkenberg, B., Andersen, J. P., & Jensen, P. H. (2018). Alpha‐synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation. EMBO reports. https://doi.org/10.15252/embr.201744617

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.